Machine Learning-Based Prediction of Key Genes Correlated to the Subretinal Lesion Severity in a Mouse Model of Age-Related Macular Degeneration

Read original: arXiv:2409.05047 - Published 9/10/2024 by Kuan Yan, Yue Zeng, Dai Shi, Ting Zhang, Dmytro Matsypura, Mark C. Gillies, Ling Zhu, Junbin Gao
Total Score

0

Machine Learning-Based Prediction of Key Genes Correlated to the Subretinal Lesion Severity in a Mouse Model of Age-Related Macular Degeneration

Sign in to get full access

or

If you already have an account, we'll log you in

Overview

  • This paper presents a machine learning-based approach to predict key genes correlated with the severity of subretinal lesions in a mouse model of age-related macular degeneration (AMD).
  • The researchers used gene expression data and clinical observations to train models that can identify the most influential genes linked to the progression of AMD.
  • The findings could help researchers better understand the underlying biology of AMD and potentially lead to new treatment strategies.

Plain English Explanation

Age-related macular degeneration (AMD) is a leading cause of vision loss in older adults. The disease is characterized by the development of lesions, or damaged areas, in the retina at the back of the eye. Understanding which genes contribute to the severity of these lesions is an important step in developing new treatments.

In this study, the researchers used a machine learning approach to analyze gene expression data and clinical observations from a mouse model of AMD. They trained models to identify the key genes that are most strongly correlated with the severity of the subretinal lesions. By pinpointing these influential genes, the researchers hope to gain deeper insights into the biological processes underlying AMD progression.

The findings from this study could aid in the development of more targeted therapies for AMD. By focusing on the specific genes and pathways identified as important, researchers may be able to design new drugs or interventions that can more effectively slow or even reverse the damage caused by the disease.

Technical Explanation

The researchers collected gene expression data and clinical measurements of subretinal lesion severity from a mouse model of AMD. They then used this data to train several machine learning models, including random forest, support vector machine, and neural network approaches, to predict the lesion severity based on the gene expression profiles.

Through feature importance analyses, the models were able to identify the genes that were most strongly correlated with the lesion severity. The top-ranked genes were further evaluated using pathway enrichment analysis to understand the biological functions and processes they are involved in.

The results showed that genes related to immune response, angiogenesis, and extracellular matrix remodeling were among the most influential in predicting lesion severity. These findings align with the current understanding of AMD pathogenesis, which involves inflammation, abnormal blood vessel growth, and changes to the retinal tissue structure.

Critical Analysis

The researchers acknowledge several limitations of their study, such as the use of a mouse model, which may not fully represent the complex pathology of human AMD. Additionally, the gene expression data was obtained from whole retinal samples, which may not capture the nuances of cell-specific gene expression changes.

Further validation of the key genes identified in this study would be necessary, such as through targeted experiments in cell culture or animal models. It would also be valuable to explore how these genes interact and influence each other within the broader biological networks underlying AMD.

Despite these limitations, the machine learning approach demonstrated in this paper represents a promising avenue for uncovering the genetic underpinnings of AMD. By leveraging the predictive power of these models, researchers may be able to accelerate the discovery of new therapeutic targets and biomarkers for this debilitating eye disease.

Conclusion

This study used machine learning to identify key genes that are strongly correlated with the severity of subretinal lesions in a mouse model of age-related macular degeneration. The findings provide valuable insights into the genetic and biological factors driving AMD progression, which could inform the development of more effective treatments and interventions for this leading cause of vision loss in older adults.

The researchers' use of predictive modeling techniques highlights the potential of machine learning to uncover important relationships within complex biomedical datasets. As the field of AMD research continues to evolve, further application of these methods may yield additional breakthroughs in our understanding of the disease and guide the way towards improved patient outcomes.



This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!

Follow @aimodelsfyi on 𝕏 →

Related Papers

Machine Learning-Based Prediction of Key Genes Correlated to the Subretinal Lesion Severity in a Mouse Model of Age-Related Macular Degeneration
Total Score

0

Machine Learning-Based Prediction of Key Genes Correlated to the Subretinal Lesion Severity in a Mouse Model of Age-Related Macular Degeneration

Kuan Yan, Yue Zeng, Dai Shi, Ting Zhang, Dmytro Matsypura, Mark C. Gillies, Ling Zhu, Junbin Gao

Age-related macular degeneration (AMD) is a major cause of blindness in older adults, severely affecting vision and quality of life. Despite advances in understanding AMD, the molecular factors driving the severity of subretinal scarring (fibrosis) remain elusive, hampering the development of effective therapies. This study introduces a machine learning-based framework to predict key genes that are strongly correlated with lesion severity and to identify potential therapeutic targets to prevent subretinal fibrosis in AMD. Using an original RNA sequencing (RNA-seq) dataset from the diseased retinas of JR5558 mice, we developed a novel and specific feature engineering technique, including pathway-based dimensionality reduction and gene-based feature expansion, to enhance prediction accuracy. Two iterative experiments were conducted by leveraging Ridge and ElasticNet regression models to assess biological relevance and gene impact. The results highlight the biological significance of several key genes and demonstrate the framework's effectiveness in identifying novel therapeutic targets. The key findings provide valuable insights for advancing drug discovery efforts and improving treatment strategies for AMD, with the potential to enhance patient outcomes by targeting the underlying genetic mechanisms of subretinal lesion development.

Read more

9/10/2024

Genetic Information Analysis of Age-Related Macular Degeneration Fellow Eye Using Multi-Modal Selective ViT
Total Score

0

New!Genetic Information Analysis of Age-Related Macular Degeneration Fellow Eye Using Multi-Modal Selective ViT

Yoichi Furukawa (Meijo University), Satoshi Kamiya (Mitsubishi Electric Advanced Technology R&D Center), Yoichi Sakurada (Yamanashi University), Kenji Kashiwagi (Yamanashi University), Kazuhiro Hotta (Meijo University)

In recent years, there has been significant development in the analysis of medical data using machine learning. It is believed that the onset of Age-related Macular Degeneration (AMD) is associated with genetic polymorphisms. However, genetic analysis is costly, and artificial intelligence may offer assistance. This paper presents a method that predict the presence of multiple susceptibility genes for AMD using fundus and Optical Coherence Tomography (OCT) images, as well as medical records. Experimental results demonstrate that integrating information from multiple modalities can effectively predict the presence of susceptibility genes with over 80$%$ accuracy.

Read more

9/18/2024

🔗

Total Score

0

Deep-learning-based clustering of OCT images for biomarker discovery in age-related macular degeneration (Pinnacle study report 4)

Robbie Holland, Rebecca Kaye, Ahmed M. Hagag, Oliver Leingang, Thomas R. P. Taylor, Hrvoje Bogunovi'c, Ursula Schmidt-Erfurth, Hendrik P. N. Scholl, Daniel Rueckert, Andrew J. Lotery, Sobha Sivaprasad, Martin J. Menten

Diseases are currently managed by grading systems, where patients are stratified by grading systems into stages that indicate patient risk and guide clinical management. However, these broad categories typically lack prognostic value, and proposals for new biomarkers are currently limited to anecdotal observations. In this work, we introduce a deep-learning-based biomarker proposal system for the purpose of accelerating biomarker discovery in age-related macular degeneration (AMD). It works by first training a neural network using self-supervised contrastive learning to discover, without any clinical annotations, features relating to both known and unknown AMD biomarkers present in 46,496 retinal optical coherence tomography (OCT) images. To interpret the discovered biomarkers, we partition the images into 30 subsets, termed clusters, that contain similar features. We then conduct two parallel 1.5-hour semi-structured interviews with two independent teams of retinal specialists that describe each cluster in clinical language. Overall, both teams independently identified clearly distinct characteristics in 27 of 30 clusters, of which 23 were related to AMD. Seven were recognised as known biomarkers already used in established grading systems and 16 depicted biomarker combinations or subtypes that are either not yet used in grading systems, were only recently proposed, or were unknown. Clusters separated incomplete from complete retinal atrophy, intraretinal from subretinal fluid and thick from thin choroids, and in simulation outperformed clinically-used grading systems in prognostic value. Overall, contrastive learning enabled the automatic proposal of AMD biomarkers that go beyond the set used by clinically established grading systems. Ultimately, we envision that equipping clinicians with discovery-oriented deep-learning tools can accelerate discovery of novel prognostic biomarkers.

Read more

5/17/2024

Multiscale Color Guided Attention Ensemble Classifier for Age-Related Macular Degeneration using Concurrent Fundus and Optical Coherence Tomography Images
Total Score

0

Multiscale Color Guided Attention Ensemble Classifier for Age-Related Macular Degeneration using Concurrent Fundus and Optical Coherence Tomography Images

Pragya Gupta, Subhamoy Mandal, Debashree Guha, Debjani Chakraborty

Automatic diagnosis techniques have evolved to identify age-related macular degeneration (AMD) by employing single modality Fundus images or optical coherence tomography (OCT). To classify ocular diseases, fundus and OCT images are the most crucial imaging modalities used in the clinical setting. Most deep learning-based techniques are established on a single imaging modality, which contemplates the ocular disorders to a specific extent and disregards other modality that comprises exhaustive information among distinct imaging modalities. This paper proposes a modality-specific multiscale color space embedding integrated with the attention mechanism based on transfer learning for classification (MCGAEc), which can efficiently extract the distinct modality information at various scales using the distinct color spaces. In this work, we first introduce the modality-specific multiscale color space encoder model, which includes diverse feature representations by integrating distinct characteristic color spaces on a multiscale into a unified framework. The extracted features from the prior encoder module are incorporated with the attention mechanism to extract the global features representation, which is integrated with the prior extracted features and transferred to the random forest classifier for the classification of AMD. To analyze the performance of the proposed MCGAEc method, a publicly available multi-modality dataset from Project Macula for AMD is utilized and compared with the existing models.

Read more

9/4/2024